PCRX - Pacira BioSciences, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue337,277286,630276,371248,997
Cost of Revenue142,533144,626155,782100,499
Gross Profit194,744142,004120,589148,498
Operating Expenses
Research Development55,68857,29057,29057,290
Selling General and Administrative177,265161,494152,613139,043
Non Recurring----
Others----
Total Operating Expenses319,798306,120308,395239,542
Operating Income or Loss17,479-19,490-32,0249,455
Income from Continuing Operations
Total Other Income/Expenses Net-17,904-22,981-5,820-7,335
Earnings Before Interest and Taxes17,479-19,490-32,0249,455
Interest Expense-21,949-18,047-7,061-7,796
Income Before Tax-425-42,471-37,8442,120
Income Tax Expense46140105264
Minority Interest----
Net Income From Continuing Ops-471-42,611-37,9491,856
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-471-42,611-37,9491,856
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-471-42,611-37,9491,856